The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Inhaled corticosteroids for stable chronic obstructive pulmonary disease
Open accessAbstract
BACKGROUND: The role of inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease (COPD) has been the subject of much controversy. Major international guidelines recommend selective use of ICS. Recently published meta-analyses have reported conflicting findings on the effects of inhaled steroid therapy in COPD. OBJECTIVES: To determine the efficacy and safety of inhaled corticosteroids in stable patients with COPD, in terms of objective and subjective outcomes. SEARCH METHODS: A pre-defined search strategy was used to search the Cochrane Airways Group Specialised Register for relevant literature. Searches are current as of July 2011. SELECTION CRITERIA: We included randomised trials comparing any dose of any type of inhaled steroid with a placebo control in patients with COPD. Acute bronchodilator reversibility to short-term beta(2)-agonists and bronchial hyper-responsiveness were not exclusion criteria. The a priori primary outcome was change in lung function. We also analysed data on mortality, exacerbations, quality of life and symptoms, rescue bronchodilator use, exercise capacity, biomarkers and safety. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trial quality and extracted data. We contacted study authors for additional information. We collected adverse effects information from the trials. MAIN RESULTS: Fifty-five primary studies with 16,154 participants met the inclusion criteria. Long-term use of ICS (more than six months) did not consistently reduce the rate of decline in forced expiratory volume in one second (FEV(1)) in COPD patients (generic inverse variance analysis: mean difference (MD) 5.80 mL/year with ICS over placebo, 95% confidence interval (CI) -0.28 to 11.88, 2333 participants; pooled means analysis: 6.88 mL/year, 95% CI 1.80 to 11.96, 4823 participants), although one major trial demonstrated a statistically significant difference. There was no statistically significant effect on mortality in COPD patients (odds ratio (OR) 0.98, 95% CI 0.83 to 1.16, 8390 participants). Long-term use of ICS reduced the mean rate of exacerbations in those studies where pooling of data was possible (generic inverse variance analysis: MD -0.26 exacerbations per patient per year, 95% CI -0.37 to -0.14, 2586 participants; pooled means analysis: MD -0.19 exacerbations per patient per year, 95% CI -0.30 to -0.08, 2253 participants). ICS slowed the rate of decline in quality of life, as measured by the St George's Respiratory Questionnaire (MD -1.22 units/year, 95% CI -1.83 to -0.60, 2507 participants). Response to ICS was not predicted by oral steroid response, bronchodilator reversibility or bronchial hyper-responsiveness in COPD patients. There was an increased risk of oropharyngeal candidiasis (OR 2.65, 95% CI 2.03 to 3.46, 5586 participants) and hoarseness. In the long-term studies, the rate of pneumonia was increased in the ICS group compared to placebo, in studies that reported pneumonia as an adverse event (OR 1.56, 95% CI 1.30 to 1.86, 6235 participants). The long-term studies that measured bone effects generally showed no major effect on fractures and bone mineral density over three years. AUTHORS' CONCLUSIONS: Patients and clinicians should balance the potential benefits of inhaled steroids in COPD (reduced rate of exacerbations, reduced rate of decline in quality of life and possibly reduced rate of decline in FEV(1)) against the potential side effects (oropharyngeal candidiasis and hoarseness, and risk of pneumonia).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Celli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., Calverley, P. M. A., Chavannes, N., Dillard, T., Fahy, B., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,421
Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease
Celli, B. R., Snider, G. L., Heffner, J. E., Tiep, B. L., Ziment, I., Make, B. J., Braman, S. S., Olsen, G. N., & D, Y. Y. P. M. (1995) · Cited by 3,506
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Chronic Obstructive Pulmonary Disease
(2018) · Questions for the Final FFICM Structured Oral Examination · doi:10.1017/9781108233712.025 · Cited by 2,689
The natural history of chronic airflow obstruction.
Fletcher, C., & Peto, R. (1977) · BMJ · doi:10.1136/bmj.1.6077.1645 · Cited by 2,370
Donaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Charbonneau, D. H. (2005) · Europe PMC (PubMed Central) · Cited by 2,041
Siafakas, N., Vermeire, P., Pride, N., Paoletti, P., Gibson, J., Howard, P., Yernault, J., Decramer, M., Higenbottam, T., Postma, D., et al. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08081398 · Cited by 1,592
Keatings, V. M., Collins, P. D., Scott, D. M., & Barnes, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564092 · Cited by 1,362
Anthonisen, N. R. (1994) · JAMA · doi:10.1001/jama.1994.03520190043033 · Cited by 1,341
Calverley, P., Pauwels, R., Vestbo, J., Jones, P., Pride, N., Gulsvik, A., Anderson, J., & Maden, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12459-2 · Cited by 1,221
Pauwels, R. A., Löfdahl, C.-G., Laitinen, L. A., Schouten, J. P., Postma, D. S., Pride, N. B., & Ohlsson, S. V. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402503 · Cited by 1,074
Solway, S., Brooks, D., Lacasse, Y., & Thomas, S. (2001) · Chest · doi:10.1378/chest.119.1.256 · Cited by 1,063
Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease
Ito, K., Ito, M., Elliott, W. M., Cosio, B., Caramori, G., Kon, O. M., Barczyk, A., Hayashi, S., Adcock, I. M., Hogg, J. C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041892 · Cited by 968
Changes in Forced Expiratory Volume in 1 Second over Time in COPD
Vestbo, J., Edwards, L. D., Scanlon, P. D., Yates, J. C., Agusti, A., Bakke, P., Calverley, P. M. A., Celli, B., Coxson, H. O., Crim, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105482 · Cited by 963
Szafranski, W., Cukier, A., Ramirez, A., Menga, G., Sansores, R., Nahabedian, S., Peterson, S., & Olsson, H. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00031402 · Cited by 887
(2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432601 · Cited by 830
Vestbo, J., Søorensen, T., Lange, P., Brix, A., Torre, P., & Viskum, K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10019-3 · Cited by 816
CD8 + T-Lymphocytes in Peripheral Airways of Smokers with Chronic Obstructive Pulmonary Disease
SAETTA, M., Di STEFANO, A., TURATO, G., FACCHINI, F. M., CORBINO, L., MAPP, C. E., MAESTRELLI, P., CIACCIA, A., & FABBRI, L. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.9709027 · Cited by 792
Wedzicha, W. (2004) · Thorax · doi:10.1136/thx.2003.awjan · Cited by 777
Efficacy and Safety of Inhaled Corticosteroids: New Developments
BARNES, P. J., PEDERSEN, S., & BUSSE, W. W. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.157315 · Cited by 749
Celli, B. R., Thomas, N. E., Anderson, J. A., Ferguson, G. T., Jenkins, C. R., Jones, P. W., Vestbo, J., Knobil, K., Yates, J. C., & Calverley, P. M. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1869oc · Cited by 748
Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease
Calverley, P. M., Boonsawat, W., Cseke, Z., Zhong, N., Peterson, S., & Olsson, H. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00027003 · Cited by 730
Smoking and Lung Function of Lung Health Study Participants after 11 Years
Anthonisen, N. R., Connett, J. E., & Murray, R. P. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2112096 · Cited by 697
Guidelines for the management of chronic obstructive pulmonary disease
Buist, A. S. (2002) · Respiratory Medicine · doi:10.1016/s0954-6111(02)80029-4 · Cited by 607
Brightling, C. E., Monteiro, W., Ward, R., Parker, D., Morgan, M. D., Wardlaw, A. J., & Pavord, I. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02872-5 · Cited by 595
Interpreting thresholds for a clinically significant change in health status in asthma and COPD
Jones, P. W. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00063702 · Cited by 585
KANNER, R. E., ANTHONISEN, N. R., & CONNETT, J. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2010017 · Cited by 583
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
Keatings, V. M., Jatakanon, A., Worsdell, Y. M., & Barnes, P. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.2.9032192 · Cited by 558
Bronchodilator reversibility testing in chronic obstructive pulmonary disease
Calverley, P. M. A. (2003) · Thorax · doi:10.1136/thorax.58.8.659 · Cited by 512
Paggiaro, P. L., Dahle, R., Bakran, I., Frith, L., Hollingworth, K., & Efthimiou, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)03471-5 · Cited by 508
Mahler, D. A., Wire, P., Horstman, D., Chang, C.-N., Yates, J., Fischer, T., & Shah, T. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2112055 · Cited by 495
Buist, A. S., & Connett, J. E. (1993) · Chest · doi:10.1378/chest.103.6.1644a · Cited by 483
Impact of preventing exacerbations on deterioration of health status in COPD
Spencer, S., Calverley, P. M. A., Burge, P. S., & Jones, P. W. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00121404 · Cited by 441
Crim, C., Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Willits, L. R., Yates, J. C., & Vestbo, J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00193908 · Cited by 432
CULPITT, S. V., MAZIAK, W., LOUKIDIS, S., NIGHTINGALE, J. A., MATTHEWS, J. L., & BARNES, P. J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.5.9811058 · Cited by 417
Contemporary Management of Chronic Obstructive Pulmonary Disease: Scientific Review
Sin, D. D., McAlister, F. A., Man, S. F. P., & Anthonisen, N. R. (2003) · JAMA · doi:10.1001/jama.290.17.2301 · Cited by 404
Sputum Eosinophilia Predicts Benefit from Prednisone in Smokers with Chronic Obstructive Bronchitis
PIZZICHINI, E., PIZZICHINI, M. M. M., GIBSON, P., PARAMESWARAN, K., GLEICH, G. J., BERMAN, L., DOLOVICH, J., & HARGREAVE, F. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9804028 · Cited by 399
Barnes, P. J., Ito, K., & Adcock, I. M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15650-x · Cited by 399
Activated T-Lymphocytes and Macrophages in Bronchial Mucosa of Subjects with Chronic Bronchitis
Saetta, M., Di Stefano, A., Maestrelli, P., Ferraresso, A., Drigo, R., Potena, A., Ciaccia, A., & Fabbri, L. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.2.301 · Cited by 383
COPD exacerbations {middle dot} 1: Epidemiology
Donaldson, G. C. (2006) · Thorax · doi:10.1136/thx.2005.041806 · Cited by 371
McKenzie, D. K., & Frith, P. A. (2003) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05213.x · Cited by 369
Brightling, C. E. (2005) · Thorax · doi:10.1136/thx.2004.032516 · Cited by 369
Drummond, M. B., Dasenbrook, E. C., Pitz, M. W., Murphy, D. J., & Fan, E. (2008) · JAMA · doi:10.1001/jama.2008.717 · Cited by 364
Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma.
Fernández‐Rivas, M., González-Mancebo, E., Rodríguez-Pérez, R., Benito, C., Sánchez-Monge, R., Salcedo, G., Alonso, M. D., Rosado, A., Tejedor, M. A., Vila, C., et al. (2003) · PubMed · doi:10.1016/s0091 · Cited by 357
Effects of Fluticasone on Systemic Markers of Inflammation in Chronic Obstructive Pulmonary Disease
Sin, D. D., Lacy, P., York, E., & Man, S. F. P. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-543oc · Cited by 347
Singh, S., Amin, A. V., & Loke, Y. K. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.550 · Cited by 346
Jenkins, C. R., Jones, P. W., Calverley, P. M., Celli, B., Anderson, J. A., Ferguson, G. T., Yates, J. C., Willits, L. R., & Vestbo, J. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-59 · Cited by 345
Kerstjens, H. A. M., Brand, P. L. P., Hughes, M. D., Robinson, N. J., Postma, D. S., Sluiter, H. J., Bleecker, E. R., Dekhuijzen, P. N. R., de Jong, P. M., Mengelers, H. J. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272003 · Cited by 341
Health Status Deterioration in Patients with Chronic Obstructive Pulmonary Disease
SPENCER, S., CALVERLEY, P. M. A., SHERWOOD BURGE, P., & JONES, P. W. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.2005009 · Cited by 334
Hanania, N. A., Darken, P., Horstman, D., Reisner, C., Lee, B., Davis, S., & Shah, T. (2003) · Chest · doi:10.1378/chest.124.3.834 · Cited by 327
Alsaeedi, A., Sin, D. D., & McAlister, F. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01143-9 · Cited by 326
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease
Sin, D. D. (2005) · Thorax · doi:10.1136/thx.2005.045385 · Cited by 307
SIN, D. D., & TU, J. V. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.4.2009033 · Cited by 305
van der Valk, P., Monninkhof, E., van der Palen, J., Zielhuis, G., & van Herwaarden, C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-512oc · Cited by 298
Corticosteroid reversibility in COPD is related to features of asthma.
Chanez, P., Vignola, A. M., O'Shaugnessy, T., Enander, I., Li, D., Jeffery, P. K., & Bousquet, J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.5.9154853 · Cited by 297
Suissa, S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1231oc · Cited by 272
Hattotuwa, K. L., Gizycki, M. J., Ansari, T. W., Jeffery, P. K., & Barnes, N. C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2105025 · Cited by 270
Loke, Y. K., Cavallazzi, R., & Singh, S. (2011) · Thorax · doi:10.1136/thx.2011.160028 · Cited by 267
Prevalence and Progression of Osteoporosis in Patients With COPD
Ferguson, G. T., Calverley, P. M. A., Anderson, J. A., Jenkins, C. R., Jones, P. W., Willits, L. R., Yates, J. C., Vestbo, J., & Celli, B. (2009) · Chest · doi:10.1378/chest.08-3016 · Cited by 265
Jones, P. W., Willits, L. R., Burge, P. S., & Calverley, P. M. A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00013303 · Cited by 249
Ollerenshaw, S. L., & Woolcock, A. J. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.4_pt_1.922 · Cited by 235
Callahan, C. M., Dittus, R. S., & Katz, B. P. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-3-216 · Cited by 233
Di Stefano, A., Maestrelli, P., Roggeri, A., Turato, G., Calabro, S., Potena, A., Mapp, C. E., Ciaccia, A., Covacev, L., & Fabbri, L. M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.3.7509705 · Cited by 228
The TORCH (TOwards a Revolution in COPD Health) survival study protocol: Fig. 1.—
The TORCH Study Group (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00120603 · Cited by 224
Sutherland, E. R. (2003) · Thorax · doi:10.1136/thorax.58.11.937 · Cited by 220
Pauwels, R., Lofdahl, C., Pride, N., Postma, D., Laitinen, L., & Ohlsson, S. (1992) · European Respiratory Journal · doi:10.1183/09031936.93.05101254 · Cited by 217
Reassessment of inflammation of airways in chronic bronchitis.
Mullen, J. B., Wright, J. L., Wiggs, B. R., Pare, P. D., & Hogg, J. C. (1985) · BMJ · doi:10.1136/bmj.291.6504.1235 · Cited by 216
Sin, D. D., Man, S. F. P., Marciniuk, D. D., Ford, G., FitzGerald, M., Wong, E., York, E., Mainra, R. R., Ramesh, W., Melenka, L. S., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1356oc · Cited by 212
Dompeling, E., van Schayck, C. P., van Grunsven, P. M., van Herwaarden, C. L. A., Akkermans, R., Molema, J., Folgering, H., & van Weel, C. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-10-199305150-00003 · Cited by 211
Cardiovascular events in patients with COPD: TORCH Study results
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Crim, C., Willits, L. R., Yates, J. C., Vestbo, J., et al. (2010) · Thorax · doi:10.1136/thx.2010.136077 · Cited by 207
Marshall, M. (1964) · PubMed · Cited by 204
Tashkin, D. P., Rennard, S. I., Martin, P., Ramachandran, S., Martin, U. J., Silkoff, P. E., & Goldman, M. (2008) · Drugs · doi:10.2165/00003495-200868140-00004 · Cited by 202
Budesonide and the risk of pneumonia: a meta-analysis of individual patient data
Sin, D. D., Tashkin, D., Zhang, X., Radner, F., Sjöbring, U., Thorén, A., Calverley, P. M., & Rennard, S. I. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61250-2 · Cited by 201
Bleomycin induces cellular senescence in alveolar epithelial cells
Aoshiba, K., Tsuji, T., & Nagai, A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00011903 · Cited by 197
Lapperre, T. S., Snoeck-Stroband, J. B., Gosman, M. M. E., Jansen, D. F., van Schadewijk, A., Thiadens, H. A., Vonk, J. M., Boezen, H. M., ten Hacken, N. H. T., Sont, J. K., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-8-200910200-00004 · Cited by 189
Celli, B., Vestbo, J., Jenkins, C. R., Jones, P. W., Ferguson, G. T., Calverley, P. M. A., Yates, J. C., Anderson, J. A., Willits, L. R., & Wise, R. A. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201004-0665oc · Cited by 186
Inhaled Corticosteroids Are Not Beneficial in Chronic Obstructive Pulmonary Disease
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.16125_2 · Cited by 185
Martin, T. R., Raghu, G., Maunder, R. J., & Springmeyer, S. C. (1985) · PubMed · doi:10.1164/arrd.1985.132.2.254 · Cited by 178
Effects of Long-term Treatment With Corticosteroids in COPD
Renkema, T. E., Schouten, J. P., Koëter, G. H., & Postma, D. S. (1996) · Chest · doi:10.1378/chest.109.5.1156 · Cited by 176
van Grunsven, P. M., van Schayck, C. P., Derenne, J. P., Kerstjens, H. A. M., Renkema, T. E. J., Postma, D. S., Similowski, T., Akkermans, R. P., Jong, P. C. M. P.-D., Dekhuijzen, P. N. R., et al. (1999) · Thorax · doi:10.1136/thx.54.1.7 · Cited by 167
Reported Pneumonia in Patients With COPD
Calverley, P. M. A., Stockley, R. A., Seemungal, T. A. R., Hagan, G., Willits, L. R., Riley, J. H., & Wedzicha, J. A. (2011) · Chest · doi:10.1378/chest.09-2992 · Cited by 161
Jarad, N. A., Wedzicha, J. A., Burge, P. S., & Calverley, P. M. A. (1999) · Respiratory Medicine · doi:10.1016/s0954-6111(99)90001-x · Cited by 160
Methodological issues in therapeutic trials of COPD
Suissa, S., Ernst, P., Vandemheen, K. L., & Aaron, S. D. (2008) · European Respiratory Journal · doi:10.1183/09031936.00098307 · Cited by 160
Burge, P. S. (2003) · Thorax · doi:10.1136/thorax.58.8.654 · Cited by 153
Bourbeau, J., Christodoulopoulos, P., Maltais, F., Yamauchi, Y., Olivenstein, R., & Hamid, Q. A. (2007) · Thorax · doi:10.1136/thx.2006.071068 · Cited by 149
The burden and impact of COPD in Asia and Africa.
Chan-Yeung, M. M. W., Ait-Khaled, N., White, N. W., Ip, M., & Tan, W. C. (2004) · PubMed · Cited by 136
Suissa, S. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1338pp · Cited by 136
Loss of Bone Density with Inhaled Triamcinolone in Lung Health Study II
Scanlon, P. D., Connett, J. E., Wise, R. A., Tashkin, D. P., Madhok, T. C., Skeans, M. A., Carpenter, P. C., Bailey, W. C., Buist, A. S., Eichenhorn, M. S., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200310-1349oc · Cited by 133
Spencer, M., Briggs, A. H., Grossman, R. F., & Rance, L. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523060-00008 · Cited by 132
Gartlehner, G. (2006) · The Annals of Family Medicine · doi:10.1370/afm.517 · Cited by 129
Martin, T. R., Pistorese, B. P., Hudson, L. D., & Maunder, R. J. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.2.254 · Cited by 128
A Pooled Analysis of FEV 1 Decline in COPD Patients Randomized to Inhaled Corticosteroids or Placebo
Soriano, J. B., Sin, D. D., Zhang, X., Camp, P. G., Anderson, J. A., Anthonisen, N. R., Buist, A. S., Burge, P. S., Calverley, P. M. A., Connett, J. E., et al. (2007) · CHEST Journal · doi:10.1378/chest.06-1696 · Cited by 128
Meta‐analysis combining parallel and cross‐over clinical trials. II: Binary outcomes
Curtin, F., Elbourne, D. R., & Altman, D. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1206 · Cited by 127
Bourbeau, J., Rouleau, M.-È., & Boucher, S. (1998) · Thorax · doi:10.1136/thx.53.6.477 · Cited by 120
Johnell, O., Pauwels, R., Lofdahl, C., Laitinen, L. A., Postma, D. S., Pride, N. B., & Ohlsson, S. V. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00276602 · Cited by 112
Withdrawal From Treatment as an Outcome in the ISOLDE Study of COPD
Calverley, P. M. A., Spencer, S., Willits, L. R., Burge, P. S., & Jones, P. (2003) · CHEST Journal · doi:10.1378/chest.124.4.1350 · Cited by 108
Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids
Schols, A. M. W. J., Wesseling, G., Kester, A. D. M., de Vries, G., Mostert, R., Slangen, J. J. M., & Wouters, E. F. �. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17303370 · Cited by 103
Exhaled Nitric Oxide and Hydrogen Peroxide in Patients with Chronic Obstructive Pulmonary Disease
Ferreira, I. M., Hazari, M. S., GUTIERREZ, C., Zamel, N., & Chapman, K. R. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.6.2012139 · Cited by 102
Inhaled Corticosteroids Are Beneficial in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.16125_1 · Cited by 101
Thompson, A. B., Mueller, M., Heires, A. J., Bohling, T., Daughton, D. M., Yancey, S. W., Sykes, R., & Rennard, S. I. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.2.389 · Cited by 98
Chronic Obstructive Lung Disease
(2005) · Springer eBooks · doi:10.1007/3-540-29623-9_5742 · Cited by 98
Inhaled beclomethasone improves the course of asthma and COPD
Dompeling, E., van Schayck, O. C. P., Molema, J., Folgering, H. T. M., van Grunsven, P. M., & van Weel, C. (1992) · European Respiratory Journal · doi:10.1183/09031936.93.05080945 · Cited by 97
Soriano, J. B., Kiri, V. A., Pride, N. B., & Vestbo, J. (2003) · American Journal of Respiratory Medicine · doi:10.1007/bf03256640 · Cited by 96
Overbeek, S. E., Kerstjens, H. A. M., Bogaard, J. M., Mulder, P. G. H., & Postma, D. S. (1996) · CHEST Journal · doi:10.1378/chest.110.1.35 · Cited by 94
Nannini, L. J., Cates, C. J., Lasserson, T., & Poole, P. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003794.pub2 · Cited by 94
Kerstjens, H. A. M., Overbeek, S. E., Schouten, J. P., Brand, P., & Postma, D. S. (1993) · European Respiratory Journal · doi:10.1183/09031936.93.06060868 · Cited by 91
Inhaled steroids and mortality in COPD: bias from unaccounted immortal time
Suissa, S. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00062504 · Cited by 89
Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter?
Sin, D. D., & Man, S. F. P. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00040803 · Cited by 84
Kerstjens, H. A. M., Postma, D. S., van Doormaal, J. J., van Zanten, A. K., Brand, P. L. P., Dekhuijzen, P. N. R., & Koëter, G. H. (1994) · Thorax · doi:10.1136/thx.49.7.652 · Cited by 83
Effects of Withdrawal of Inhaled Steroids in Men with Severe Irreversible Airflow Obstruction
O’Brien, A., Russo-Magno, P. M., Karki, A., Hiranniramol, S., HARDIN, M. B., Kaszuba, M., Sherman, C. B., & Rounds, S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2002052 · Cited by 81
Eliasson, O., Hoffman, J., Trueb, D., Frederick, D., & McCormick, J. R. (1986) · CHEST Journal · doi:10.1378/chest.89.4.484 · Cited by 80
Kaptein, A., Brand, P., Dekker, F. W., Kerstjens, H. A. M., Postma, D. S., & Sluiter, H. (1993) · European Respiratory Journal · doi:10.1183/09031936.93.06101479 · Cited by 77
Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis
Schermer, T. R., Chavannes, N. H., Dekhuijzen, R. P. N., Wouters, E. F. �., Muris, J. W. M., Akkermans, R. L. C., van Schayck, O. C. P., & van Weel, C. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2008.11.003 · Cited by 73
Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness
Verhoeven, G. T. (2002) · Thorax · doi:10.1136/thorax.57.8.694 · Cited by 71
Weir, D. C., & Burge, P. S. (1993) · Thorax · doi:10.1136/thx.48.4.309 · Cited by 70
The Influence of an Inhaled Steroid on Quality of Life in Patients With Asthma or COPD
van Schayck, O. C. P., Dompeling, E., Mölken, M. R., Folgering, H. T. M., van den Boom, G., & van Weel, C. (1995) · CHEST Journal · doi:10.1378/chest.107.5.1199 · Cited by 68
Inhaled Corticosteroids vs Placebo for Preventing COPD Exacerbations
Agarwal, R., Aggarwal, A. N., Gupta, D., et al. (2009) · CHEST Journal · doi:10.1378/chest.09-1305 · Cited by 68
Weir, D. C., Bale, G., Bright, P., & Burge, P. S. (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00021.x · Cited by 67
One-year treatment with mometasone furoate in chronic obstructive pulmonary disease
Calverley, P. M. A., Rennard, S. I., Nelson, H. S., Karpel, J. P., Abbate, E. H., Stryszak, P., & Staudinger, H. W. (2008) · Respiratory Research · doi:10.1186/1465-9921-9-73 · Cited by 66
Skin Manifestations of Inhaled Corticosteroids in COPD Patients
Tashkin, D. P., Murray, H. E., Skeans, M. A., & Murray, R. P. (2004) · CHEST Journal · doi:10.1016/s0012-3692(15)31287-3 · Cited by 62
Yıldız, F., Kaur, A., Ilgazlı, A., et al. (2000) · Respiration · doi:10.1159/000029466 · Cited by 61
Vestbo, J. (2005) · Thorax · doi:10.1136/thx.2004.025411 · Cited by 61
Senderovitz, T., Vestbo, J., Frandsen, J., Maltbæk, N., Nørgaard, M., Nielsen, C., Kampmann, J. P., & The Danish Society of Respiratory Medicine (1999) · Respiratory Medicine · doi:10.1016/s0954-6111(99)90038-0 · Cited by 59
Effects of Corticosteroids on Systemic Inflammation in Chronic Obstructive Pulmonary Disease
Man, S. F. P., & Sin, D. D. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200406-034ms · Cited by 57
Egan, J., Maden, C., Kalra, S., Adams, J. E., Eastell, R., & Woodcock, A. A. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.13f09.x · Cited by 56
van Grunsven, P. M., van Schayck, O. C. P., van Deuveren, M., van Herwaarden, C., Akkermans, R. P., & van Weel, C. (2000) · Journal of Asthma · doi:10.3109/02770900009055445 · Cited by 54
BOOM, G. V. D., Mölken, M. R., Molema, J., TIRIMANNA, P. R. S., van Weel, C., & van Schayck, O. C. P. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.11.2003151 · Cited by 47
Do patients with COPD benefit from treatment with inhaled corticosteroids?
van Schayck, C., van Grunsven, P., & Dekhuijzen, P. R. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09101969 · Cited by 38
Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists
Mapel, D. W., Hurley, J. S., Roblin, D. W., Roberts, M. H., Davis, K. J., Schreiner, R., & Frost, F. J. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.08.006 · Cited by 36
John, M., Bosse, S., Oltmanns, U., Schumacher, A., & Witt, C. C. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.03.034 · Cited by 33
Make, B. J., Hanania, N. A., ZuWallack, R., Kalberg, C. J., Emmett, A. H., Brown, C., & Knobil, K. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.05.009 · Cited by 32
Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Is There a Clinical Benefit?
Man, S. F. P., & Sin, D. D. (2005) · Drugs · doi:10.2165/00003495-200565050-00001 · Cited by 28
Corticosteroids in chronic airways obstruction: Can the patient's assessment be ignored?
Williams, I. P., & McGavin, C. R. (1980) · British Journal of Diseases of the Chest · doi:10.1016/0007-0971(80)90025-x · Cited by 28
Oral corticosteroid trials in the management of stable chronic obstructive pulmonary disease
Davies, L. (1999) · QJM · doi:10.1093/qjmed/92.7.395 · Cited by 28
Bale, G., Martínez‐Camblor, P., Burge, P. S., & Soriano, J. B. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.04.001 · Cited by 27
Murdoch, J., & Barnes, J. A. (1986) · doi:10.1007/978-1-349-09107-2_6 · Cited by 27
Inhaled corticosteroids in COPD and the risk of pneumonia
Welte, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61540-3 · Cited by 26
COPD exacerbations {middle dot} 4: Prevention
Scott, S., Walker, P., & Calverley, P. M. A. (2006) · Thorax · doi:10.1136/thx.2005.041848 · Cited by 25
Efficacy of Inhaled Steroids in Undiagnosed Subjects at High Risk for COPD
Albers, M., Schermer, T. R., van den Boom, G., Akkermans, R. L. C., van Schayck, O. C. P., van Herwaarden, C., & van Weel, C. (2004) · CHEST Journal · doi:10.1378/chest.126.6.1815 · Cited by 25
Löfdahl, C. G., Postma, D. S., Laitinen, L. A., Ohlsson, S. V., Pauwels, R., & Pride, N. B. (1998) · Respiratory Medicine · doi:10.1016/s0954-6111(98)90293-1 · Cited by 22
Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD
Guenette, J. A., Raghavan, N., Harris-McAllister, V., Preston, M. E., Webb, K. A., & O’Donnell, D. E. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.08.021 · Cited by 20
Benefits and Risks of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
Bonay, M., Bancal, C., & Crestani, B. (2002) · Drug Safety · doi:10.2165/00002018-200225010-00005 · Cited by 19
So inhaled steroids slow the rate of decline of FEV1 in patients with COPD after all?
Burge, P. S. (2003) · Thorax · doi:10.1136/thorax.58.11.911 · Cited by 19
Chavannes, N. H., Schermer, T. R., Wouters, E. F. �., et al. (2009) · International Journal of COPD · doi:10.2147/copd.s8196 · Cited by 17
Steroids in COPD: still up in the air?: Fig. 1—
Sin, D. D., & Man, S. F. P. (2010) · European Respiratory Journal · doi:10.1183/09031936.00006710 · Cited by 15
The risk/benefit of inhaled corticosteroids in chronic obstructive pulmonary disease
Bonay, M., Bancal, C., & Crestani, B. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.2.251 · Cited by 9
Sin, D. D., & Man, S. F. P. (2003) · Drugs & Aging · doi:10.2165/00002512-200320120-00001 · Cited by 8
Inhaled corticosteroids in COPD: a light at the end of the tunnel?
Wedzicha, J. A. (2005) · Thorax · doi:10.1136/thx.2005.053454 · Cited by 6
Riancho, J. A., Cubián, I., & Portero‐Sanchez, I. (2002) · Medicina Clínica · doi:10.1016/s0025-7753(02)72416-0 · Cited by 5
Wynne, M. E., & Brown, R. T. (2008) · Wiley eBooks · doi:10.1002/9780470373699.speced0691 · Cited by 2
Role of corticosteroids in stable chronic obstructive pulmonary disease
PAUWELS, R. A. (2001) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200103000-00005 · Cited by 2
A simple method for converting an odds ratio to effect size for use in meta-analysis
Chinn, S. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001130)19:22<3127::aid-sim784>3.0.co;2-m
Cited by
Spruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Glucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00214-2017 · Cited by 881
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1564 · Cited by 694
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · Respirology · doi:10.1111/resp.13012 · Cited by 681
Metadata
- Authors
- Yang, I. A., Clarke, M. S., Sim, E. H., & Fong, K. M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2012-07-11
- Volume
- 2016
- Issue
- 8
- Pages
- CD002991-CD002991
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1983772324
- Cited by
- 523
- References
- 159
- FWCI
- 33.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.